Edition:
United States

ImmuCell Corp (ICCC.OQ)

ICCC.OQ on NASDAQ Stock Exchange Capital Market

7.28USD
23 May 2018
Change (% chg)

$0.04 (+0.55%)
Prev Close
$7.24
Open
$7.30
Day's High
$7.30
Day's Low
$7.28
Volume
200
Avg. Vol
1,363
52-wk High
$9.25
52-wk Low
$5.29

Latest Key Developments (Source: Significant Developments)

ImmuCell Q1 Loss Per Share $0.04
Monday, 14 May 2018 04:05pm EDT 

May 14 (Reuters) - ImmuCell Corp ::IMMUCELL ANNOUNCES FINANCIAL RESULTS FOR FIRST QUARTER OF 2018.Q1 LOSS PER SHARE $0.04.  Full Article

ImmuCell Corp Announces Pricing Of $3 Mln Public Offering Of Common Shares
Tuesday, 19 Dec 2017 06:30am EST 

Dec 19 (Reuters) - Immucell Corp ::IMMUCELL CORPORATION ANNOUNCES PRICING OF $3 MILLION PUBLIC OFFERING OF COMMON SHARES.IMMUCELL CORP - UNDERWRITTEN PUBLIC OFFERING OF 417,807 SHARES OF STOCK AT A PRICE TO PUBLIC OF $7.30 PER SHARE.IMMUCELL CORP - ALSO ANNOUNCED ESTIMATED REVENUES FOR TWELVE-MONTH PERIOD ENDED NOVEMBER 30, 2017 EXPECTED TO INCREASE BY 9% TO $10.2 MILLION.  Full Article

Immucell Q3 loss per share $0.07
Monday, 13 Nov 2017 04:05pm EST 

Nov 13 (Reuters) - Immucell Corp ::Immucell announces financial results for third quarter of 2017.Q3 loss per share $0.07.Immucell - ‍during 3-month period ended Sept 30, 2017, total product sales were just over $2 million versus just under $2 million during same quarter of 2016​.  Full Article

Immucell Q4 sales fell 18 pct
Thursday, 9 Feb 2017 04:05pm EST 

Immucell Corp : Immucell announces preliminary 2016 financial results .Q4 sales fell 18 percent to $2.2 million.  Full Article

Immucell Corp sees FDA approval for Mast Out in 2019
Tuesday, 11 Oct 2016 11:45am EDT 

Immucell Corp :Immucell Corp - U.S. FDA approval for co's product Mast Out anticipated in 2019, allowing for two, six-month reviews of cmc technical section by FDA.  Full Article

Immucell posts Q2 earnings per share $0.00
Thursday, 11 Aug 2016 04:05pm EDT 

Immucell Corp : Immucell announces second quarter 2016 financial results . Q2 sales rose 21 percent to $2.4 million .Q2 earnings per share $0.00.  Full Article

BRIEF-ImmuCell Q1 Loss Per Share $0.04

* IMMUCELL ANNOUNCES FINANCIAL RESULTS FOR FIRST QUARTER OF 2018

No consensus analysis data available.